NO20022334L - Ny sammensetning og anvendelse - Google Patents

Ny sammensetning og anvendelse

Info

Publication number: NO20022334L
Authority: NO; Norway
Prior art keywords: application; new composition; composition; new
Prior art date: 1999-11-16

Application number

NO20022334A

Other languages

English (en)

Other versions

NO329926B1 (no

NO20022334D0 (no

Inventor

Nicola Jayne Lilliott

Donald Colin Mackenzie

Karen Lewis

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-16

Filing date

2002-05-15

Publication date

2002-07-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27447849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20022334(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-16 Priority claimed from GBGB9927119.9A external-priority patent/GB9927119D0/en

1999-11-16 Priority claimed from GBGB9927120.7A external-priority patent/GB9927120D0/en

2000-05-31 Priority claimed from GB0013236A external-priority patent/GB0013236D0/en

2000-05-31 Priority claimed from GB0013240A external-priority patent/GB0013240D0/en

2002-05-15 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2002-05-15 Publication of NO20022334D0 publication Critical patent/NO20022334D0/no

2002-07-09 Publication of NO20022334L publication Critical patent/NO20022334L/no

2011-01-24 Publication of NO329926B1 publication Critical patent/NO329926B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20022334A 1999-11-16 2002-05-15 Farmasoytisk sammensetning og fremgangsmate for fremstilling derav NO329926B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9927119.9A GB9927119D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GBGB9927120.7A GB9927120D0 (en)	1999-11-16	1999-11-16	Novel composition and use
GB0013236A GB0013236D0 (en)	2000-05-31	2000-05-31	Novel composition and use
GB0013240A GB0013240D0 (en)	2000-05-31	2000-05-31	Novel composition and use
PCT/GB2000/004368 WO2001035941A2 (en)	1999-11-16	2000-11-16	Novel composition based on a thiazolidinedione and metformin and use

Publications (3)

Publication Number	Publication Date
NO20022334D0 NO20022334D0 (no)	2002-05-15
NO20022334L true NO20022334L (no)	2002-07-09
NO329926B1 NO329926B1 (no)	2011-01-24

Family

ID=27447849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022334A NO329926B1 (no)	1999-11-16	2002-05-15	Farmasoytisk sammensetning og fremgangsmate for fremstilling derav

Country Status (40)

Country	Link
US (1)	US8236345B2 (no)
EP (3)	EP1913945A3 (no)
JP (2)	JP4865975B2 (no)
KR (1)	KR100760063B1 (no)
CN (1)	CN1222290C (no)
AP (1)	AP1389A (no)
AR (2)	AR030920A1 (no)
AT (1)	ATE292466T1 (no)
AU (3)	AU775654B2 (no)
BG (1)	BG65616B1 (no)
BR (1)	BR0015605A (no)
CA (1)	CA2388846A1 (no)
CO (1)	CO5300392A1 (no)
CZ (1)	CZ302500B6 (no)
DE (1)	DE60019329T2 (no)
DK (1)	DK1231918T3 (no)
DZ (1)	DZ3251A1 (no)
EA (1)	EA004878B1 (no)
ES (1)	ES2240199T3 (no)
HK (1)	HK1049788B (no)
HR (1)	HRP20020416B1 (no)
HU (1)	HU229960B1 (no)
IL (3)	IL149618A0 (no)
MA (1)	MA25567A1 (no)
ME (1)	ME00318B (no)
MX (1)	MXPA02005005A (no)
MY (1)	MY125516A (no)
NO (1)	NO329926B1 (no)
NZ (1)	NZ518946A (no)
OA (1)	OA12513A (no)
PE (1)	PE20011011A1 (no)
PL (1)	PL200943B1 (no)
PT (1)	PT1231918E (no)
RS (1)	RS51343B (no)
SI (1)	SI1231918T1 (no)
SK (1)	SK286985B6 (no)
TW (1)	TWI240626B (no)
UA (1)	UA73150C2 (no)
UY (1)	UY26439A1 (no)
WO (1)	WO2001035941A2 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001257456B2 (en) *	2000-05-01	2006-02-09	Aeropharm Technology, Inc.	A core formulation
MXPA04000181A (es) *	2001-07-10	2004-11-22	Kos Life Sciences Inc	Formulacion de nucleo que comprende troglitazona y una biguanida.
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US8911781B2 (en) *	2002-06-17	2014-12-16	Inventia Healthcare Private Limited	Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
CA2492722A1 (en) *	2002-07-11	2004-01-22	Takeda Pharmaceutical Company Limited	Production method of coated preparations
US8637512B2 (en) *	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
KR20100137023A (ko) *	2002-09-20	2010-12-29	안드렉스 랩스 엘엘씨	약제학적 정제
US7785627B2 (en) *	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
UA80991C2 (en) *	2002-10-07	2007-11-26		Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
BRPI0407074A (pt)	2003-01-29	2006-01-24	Takeda Pharmaceutical	Método para produção de uma preparação revestida, preparação revestida, e, método para melhorar a dissolução do cloridreto de pioglitazona de uma preparação revestida com cloridreto de pioglitazona
FR2858556B1 (fr) *	2003-08-06	2006-03-10	Galenix Innovations	Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US8263121B2 (en)	2004-04-14	2012-09-11	Takeda Pharmaceutical Company Limited	Solid pharmaceutical preparation
WO2006011397A1 (ja) *	2004-07-27	2006-02-02	Kowa Company., Ltd.	糖尿病の予防または治療のための薬剤
PL1878426T3 (pl) *	2005-04-26	2010-11-30	Sumitomo Dainippon Pharma Co Ltd	Preparat w formie granulatu zawierający związek biguanidu
HRP20160679T1 (hr) *	2005-12-22	2016-07-15	Takeda Pharmaceutical Company Limited	Kruti pripravak koji sadrži senzibilizator inzulina
FR2896159B1 (fr)	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
JP4893750B2 (ja)	2006-12-26	2012-03-07	富士通株式会社	データ圧縮装置およびデータ復元装置
ME01239B (me)	2007-02-01	2013-06-20	Takeda Pharmaceuticals Co	Čvrsti preparat koji sadrži alogliptin i pioglitazon
HRP20141008T1 (hr)	2007-02-09	2015-01-02	Alphapharm Pty Ltd	Oblik doziranja koji sadrži dva aktivna farmaceutska sastojka u razliäśitim fizikalnim oblicima
TR200803177A2 (tr) *	2008-05-06	2009-11-23	Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş.	Antihiperglisemik etkili metformîn - pioglitazon formülasyonu.
US8846315B2 (en)	2008-08-12	2014-09-30	Zinfandel Pharmaceuticals, Inc.	Disease risk factors and methods of use
NZ710443A (en)	2008-08-12	2019-03-29	Zinfandel Pharmaceuticals Inc	Method of identifying disease risk factors
FR2951945B1 (fr) *	2009-11-05	2013-08-09	Sanofi Aventis	Composition pharmaceutique
JP5775522B2 (ja) *	2009-11-13	2015-09-09	アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａＡｋｔｉｅｂｏｌａｇ	二層錠製剤
EP2441442A1 (en)	2010-10-08	2012-04-18	LEK Pharmaceuticals d.d.	A pharmaceutical composition comprising a thiazolidinedione
US9211263B2 (en)	2012-01-06	2015-12-15	Elcelyx Therapeutics, Inc.	Compositions and methods of treating metabolic disorders
US8796338B2 (en)	2011-01-07	2014-08-05	Elcelyx Therapeutics, Inc	Biguanide compositions and methods of treating metabolic disorders
US9480663B2 (en)	2011-01-07	2016-11-01	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
US11974971B2 (en)	2011-01-07	2024-05-07	Anji Pharmaceuticals Inc.	Compositions and methods for treating metabolic disorders
AU2012204162B2 (en)	2011-01-07	2017-04-20	Anji Pharmaceuticals Inc.	Chemosensory receptor ligand-based therapies
US11759441B2 (en)	2011-01-07	2023-09-19	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en)	2011-01-07	2017-02-21	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
AU2012205798B2 (en)	2011-01-10	2016-02-25	Takeda Pharmaceutical Company Limited	Methods and drug products for treating Alzheimer's disease
KR102231554B1 (ko)	2012-01-06	2021-03-23	앤지 파마 유에스 엘엘씨	대사 장애를 치료하는 조성물 및 방법
KR102035879B1 (ko)	2012-01-06	2019-10-23	엘셀릭스 테라퓨틱스 인코포레이티드	바이구아나이드 조성물 및 대사 장애를 치료하는 방법
CN108451923B (zh) *	2018-05-31	2025-05-06	常州兰陵制药有限公司	盐酸二甲双胍速释胶囊及其制备方法
WO2021196951A1 (zh)	2020-04-01	2021-10-07	杭州中美华东制药有限公司	Glp-1受体激动剂游离碱的药学上可接受的酸式盐及其制备方法
CN115461344B (zh)	2020-04-01	2024-01-12	杭州中美华东制药有限公司	一种glp-1受体激动剂的晶型a及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4613596Y1 (no) *	1969-06-02	1971-05-14
DE2347531A1 (de) *	1973-09-21	1975-04-30	Hoechst Ag	Arzneizubereitungen zur oralen diabetes-behandlung
EP0306228B1 (en) *	1987-09-04	1999-11-17	Beecham Group Plc	Substituted thiazolidinedione derivatives
US4999226A (en) *	1988-06-01	1991-03-12	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
JPH0553521A (ja)	1991-08-28	1993-03-05	Mitsubishi Electric Corp	オートトラツキング型ｃｒｔデイスプレイモニタ
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en) *	1993-09-21	2001-02-06	Jagotec Ag	Pharmaceutical tablet capable of liberating one or more drugs at different release rates
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
DE19539361A1 (de) *	1995-10-23	1997-04-24	Basf Ag	Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
GB9612496D0 (en)	1996-06-14	1996-08-14	De La Rue Thomas & Co Ltd	Security device
PE71699A1 (es)	1997-02-07	1999-08-03	Sepracor Inc	Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
AP1279A (en) *	1997-06-18	2004-05-20	Smithkline Beecham Plc	Treatment of diabetes with thiazolidinedione and metformin.
US20020004515A1 (en) *	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
GB9715295D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
CA2320900C (en)	1998-03-19	2009-10-27	Bristol-Myers Squibb Company	Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets
US20040081697A1 (en) *	1998-11-12	2004-04-29	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2000028989A1 (en)	1998-11-12	2000-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) *	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
DZ2937A1 (fr)	1998-11-12	2004-03-15	Smithkline Beecham Plc	Compositions nouvelles de sensibilidants à l'insuline.
GB9824893D0 (en)	1998-11-12	1999-01-06	Smithkline Beckman Corp	Novel method of treatment
WO2001035940A2 (en)	1999-11-16	2001-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
US6461639B2 (en) *	2000-05-01	2002-10-08	Aeropharm Technology, Inc.	Core formulation
US6780432B1 (en) *	2000-05-01	2004-08-24	Aeropharm Technology, Inc.	Core formulation
US6451342B2 (en) *	2000-05-01	2002-09-17	Aeropharm Technology Incorporated	Core formulation comprised of troglitazone and a biguanide
US6403121B1 (en) *	2000-05-01	2002-06-11	Aeropharm Technology Incorporated	Core formulation
US6524621B2 (en) *	2000-05-01	2003-02-25	Aeropharm Technology Inc.	Core formulation
US6296874B1 (en) *	2000-05-01	2001-10-02	Aeropharm Technology Incorporated	Core formulation comprising troglitazone and abiguanide
GB0318824D0 (en) *	2003-08-11	2003-09-10	Glaxo Group Ltd	Novel composition

2000
- 2000-11-15 AR ARP000106019A patent/AR030920A1/es active IP Right Grant
- 2000-11-15 MY MYPI20005360A patent/MY125516A/en unknown
- 2000-11-16 WO PCT/GB2000/004368 patent/WO2001035941A2/en not_active Ceased
- 2000-11-16 AP APAP/P/2002/002505A patent/AP1389A/en active
- 2000-11-16 SK SK679-2002A patent/SK286985B6/sk not_active IP Right Cessation
- 2000-11-16 JP JP2001537934A patent/JP4865975B2/ja not_active Expired - Lifetime
- 2000-11-16 RS YUP-388/02A patent/RS51343B/sr unknown
- 2000-11-16 CA CA002388846A patent/CA2388846A1/en not_active Abandoned
- 2000-11-16 SI SI200030697T patent/SI1231918T1/xx unknown
- 2000-11-16 OA OA1200200145A patent/OA12513A/en unknown
- 2000-11-16 CZ CZ20021679A patent/CZ302500B6/cs not_active IP Right Cessation
- 2000-11-16 DE DE60019329T patent/DE60019329T2/de not_active Expired - Lifetime
- 2000-11-16 NZ NZ518946A patent/NZ518946A/en not_active IP Right Cessation
- 2000-11-16 PE PE2000001226A patent/PE20011011A1/es not_active Application Discontinuation
- 2000-11-16 UY UY26439A patent/UY26439A1/es not_active IP Right Cessation
- 2000-11-16 HK HK03100745.5A patent/HK1049788B/en not_active IP Right Cessation
- 2000-11-16 HU HU0204122A patent/HU229960B1/hu unknown
- 2000-11-16 ME MEP-2008-340A patent/ME00318B/me unknown
- 2000-11-16 BR BR0015605-1A patent/BR0015605A/pt not_active Application Discontinuation
- 2000-11-16 EP EP07120386A patent/EP1913945A3/en not_active Withdrawn
- 2000-11-16 EA EA200200571A patent/EA004878B1/ru not_active IP Right Cessation
- 2000-11-16 UA UA2002064826A patent/UA73150C2/uk unknown
- 2000-11-16 EP EP04078538A patent/EP1520581A1/en not_active Withdrawn
- 2000-11-16 MX MXPA02005005A patent/MXPA02005005A/es active IP Right Grant
- 2000-11-16 KR KR1020027006271A patent/KR100760063B1/ko not_active Expired - Lifetime
- 2000-11-16 AT AT00976156T patent/ATE292466T1/de active
- 2000-11-16 CN CNB008178224A patent/CN1222290C/zh not_active Expired - Lifetime
- 2000-11-16 AU AU14040/01A patent/AU775654B2/en not_active Expired
- 2000-11-16 PT PT00976156T patent/PT1231918E/pt unknown
- 2000-11-16 HR HR20020416A patent/HRP20020416B1/xx not_active IP Right Cessation
- 2000-11-16 EP EP00976156A patent/EP1231918B1/en not_active Expired - Lifetime
- 2000-11-16 DK DK00976156T patent/DK1231918T3/da active
- 2000-11-16 IL IL14961800A patent/IL149618A0/xx unknown
- 2000-11-16 ES ES00976156T patent/ES2240199T3/es not_active Expired - Lifetime
- 2000-11-16 PL PL355331A patent/PL200943B1/pl unknown
- 2000-11-16 DZ DZ003251A patent/DZ3251A1/fr active
- 2000-11-20 CO CO00088045A patent/CO5300392A1/es not_active Application Discontinuation
- 2000-12-04 TW TW089125730A patent/TWI240626B/zh not_active IP Right Cessation
2002
- 2002-05-13 IL IL149618A patent/IL149618A/en unknown
- 2002-05-15 MA MA26640A patent/MA25567A1/fr unknown
- 2002-05-15 NO NO20022334A patent/NO329926B1/no not_active IP Right Cessation
- 2002-05-29 BG BG106747A patent/BG65616B1/bg unknown
2004
- 2004-11-04 AU AU2004226955A patent/AU2004226955B2/en not_active Expired
2006
- 2006-12-05 AR ARP060105370A patent/AR057970A2/es active IP Right Grant
2007
- 2007-07-18 US US11/779,546 patent/US8236345B2/en not_active Expired - Fee Related
2008
- 2008-03-17 IL IL190220A patent/IL190220A0/en unknown
- 2008-08-18 AU AU2008207375A patent/AU2008207375A1/en not_active Abandoned
2011
- 2011-08-11 JP JP2011175883A patent/JP5282130B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NZ518946A (en)	2003-10-31
HUP0204122A2 (hu)	2003-03-28
JP2003514012A (ja)	2003-04-15
BG106747A (en)	2003-01-31
YU38802A (sh)	2005-03-15
MXPA02005005A (es)	2003-10-14
SK286985B6 (sk)	2009-08-06
PL200943B1 (pl)	2009-02-27
EP1231918B1 (en)	2005-04-06
MY125516A (en)	2006-08-30
ES2240199T3 (es)	2005-10-16
AU2004226955A1 (en)	2004-12-02
PT1231918E (pt)	2005-08-31
CA2388846A1 (en)	2001-05-25
KR100760063B1 (ko)	2007-09-18
EP1231918A2 (en)	2002-08-21
BG65616B1 (bg)	2009-03-31
US8236345B2 (en)	2012-08-07
HRP20020416A2 (en)	2004-08-31
AU1404001A (en)	2001-05-30
HK1049788B (en)	2005-11-04
JP4865975B2 (ja)	2012-02-01
AU2004226955B2 (en)	2008-08-28
JP2011252007A (ja)	2011-12-15
NO329926B1 (no)	2011-01-24
PE20011011A1 (es)	2001-10-28
DK1231918T3 (da)	2005-08-01
AR030920A1 (es)	2003-09-03
IL149618A0 (en)	2002-12-01
JP5282130B2 (ja)	2013-09-04
SI1231918T1 (en)	2005-08-31
US20070275054A1 (en)	2007-11-29
WO2001035941A2 (en)	2001-05-25
EP1520581A1 (en)	2005-04-06
CN1414852A (zh)	2003-04-30
AU2008207375A1 (en)	2008-09-11
TWI240626B (en)	2005-10-01
IL149618A (en)	2008-07-08
WO2001035941A8 (en)	2002-08-29
NO20022334D0 (no)	2002-05-15
HU229960B1 (hu)	2015-03-30
HRP20020416B1 (hr)	2011-04-30
MEP34008A (en)	2011-02-10
EP1913945A2 (en)	2008-04-23
BR0015605A (pt)	2002-07-09
UY26439A1 (es)	2001-07-31
CO5300392A1 (es)	2003-07-31
ME00318B (me)	2011-05-10
ATE292466T1 (de)	2005-04-15
EP1913945A3 (en)	2008-04-30
EA004878B1 (ru)	2004-08-26
AP2002002505A0 (en)	2002-06-30
UA73150C2 (uk)	2005-06-15
WO2001035941A3 (en)	2002-05-23
MA25567A1 (fr)	2002-10-01
KR20030019300A (ko)	2003-03-06
HUP0204122A3 (en)	2006-01-30
AR057970A2 (es)	2007-12-26
EA200200571A1 (ru)	2002-12-26
SK6792002A3 (en)	2002-09-10
AP1389A (en)	2005-04-14
OA12513A (en)	2006-05-29
DZ3251A1 (fr)	2001-05-25
CN1222290C (zh)	2005-10-12
PL355331A1 (en)	2004-04-19
RS51343B (sr)	2011-02-28
DE60019329T2 (de)	2006-03-09
CZ302500B6 (cs)	2011-06-22
AU775654B2 (en)	2004-08-12
HK1049788A1 (en)	2003-05-30
IL190220A0 (en)	2008-11-03
DE60019329D1 (de)	2005-05-12

Publication	Publication Date	Title
NO20022334L (no)	2002-07-09	Ny sammensetning og anvendelse
DK1233964T3 (da)	2005-09-19	Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK1112003T3 (da)	2003-08-04	Ny sammensætning og anvendelse
NO991151D0 (no)	1999-03-10	Forbindelse og anvendelse derav
EP1298180A4 (en)	2005-03-09	HYDROPHOBIC AND LIPOPHOBE COMPOSITION
NO20013393L (no)	2001-07-09	Bronnsementeringsfremgangsmater og sammensetninger
NO20006488D0 (no)	2000-12-19	Sammensetning og anvendelse
NO20021116D0 (no)	2002-03-06	Ny sammensetning
NO20000847L (no)	2000-08-23	Elastiske brønnsementsammensetninger og fremgangsmÕter
DK1339292T3 (da)	2010-04-12	Sammensætning og fremgangsmåde
NO20000011D0 (no)	2000-01-03	Skumdempersammensetninger og fremgangsmåter
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
IS6411A (is)	2002-06-06	Kaspasa tálmar og notkun þeirra
NO20021449D0 (no)	2002-03-22	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
NO20021115D0 (no)	2002-03-06	Ny sammensetning
PT1139761E (pt)	2003-10-31	Composicoes herbicidas e concentrados tensioactivos
DE69916503D1 (de)	2004-05-19	Poliermittelzusammensetzung und anwendungsverfahren
DE69916694D1 (de)	2004-06-03	2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE60028486D1 (de)	2006-07-20	Videocoder und -decoder
NO20013085D0 (no)	2001-06-21	Fosfororganiske forbindelser og deres anvendelse
NO20006626D0 (no)	2000-12-22	Beleggingsmiddel og anvendelse herav
NO20005763L (no)	2001-01-10	DHEA-sammensetning og fremgangsmåte
FIU990494U0 (fi)	1999-12-03	Uusi koostumus
NO20005483L (no)	2000-12-08	Ny sammensetning

Legal Events

Date	Code	Title	Description
2020-12-07	MK1K	Patent expired